Gossamer Bio, Inc. (GOSS)
NASDAQ: GOSS · Real-Time Price · USD
2.465
+0.045 (1.86%)
Oct 31, 2025, 1:19 PM EDT - Market open
Gossamer Bio Stock Forecast
Stock Price Forecast
The 5 analysts that cover Gossamer Bio stock have a consensus rating of "Strong Buy" and an average price target of $8.60, which forecasts a 248.88% increase in the stock price over the next year. The lowest target is $5.00 and the highest is $11.
Price Target: $8.60 (+248.88%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 10, 2025.
Analyst Ratings
The average analyst rating for Gossamer Bio stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | May '25 | Jun '25 | Jul '25 | Aug '25 | Sep '25 | Oct '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 4 | 4 | 4 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Sep 11, 2025 |
| UBS | UBS | Hold → Strong Buy Upgrades $1.25 → $9 | Hold → Strong Buy | Upgrades | $1.25 → $9 | +265.11% | Sep 10, 2025 |
| Wedbush | Wedbush | Buy Maintains $4 → $5 | Buy | Maintains | $4 → $5 | +102.84% | Aug 6, 2025 |
| Scotiabank | Scotiabank | Buy Initiates $11 | Buy | Initiates | $11 | +346.25% | Jul 14, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Maintains $7 → $8 | Strong Buy | Maintains | $7 → $8 | +224.54% | May 16, 2025 |
Financial Forecast
Revenue This Year
37.92M
from 114.70M
Decreased by -66.94%
Revenue Next Year
44.03M
from 37.92M
Increased by 16.11%
EPS This Year
-0.69
from -0.25
EPS Next Year
-0.52
from -0.69
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 70.1M | 126.4M | |||
| Avg | 37.9M | 44.0M | |||
| Low | 21.0M | n/a |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -38.8% | 233.4% | |||
| Avg | -66.9% | 16.1% | |||
| Low | -81.7% | - |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | -0.54 | -0.12 | |||
| Avg | -0.69 | -0.52 | |||
| Low | -0.75 | -0.87 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.